Decades of research by the world’s most respected cancer scientists and physicians consistently reveals one conclusion:
This fact led Anpac Bio Co-Founders, Dr. Chris Yu and Dr. Herbert Yu, to ask the question that ultimately launched the company:
Achieving that goal became the Anpac Co-Founders’ quest. They began breaking the problem apart—drawing on expertise in cancer research, bio-chemistry, chemistry, nano-technology, surface science, material science, detection, physics, engineering and manufacturing.
Together they founded Anpac Bio-Medical Science Co., Ltd. in 2008, bringing together a multi-national team of medical, biomedical and nanotechnology scientists, and engineering experts. Their unique, cross-disciplinary approach combines medicine, biochemistry, chemistry, materials, fluid mechanics, signal detection and processing, physics, precision machine engineering, and software engineering—to achieve vastly superior early cancer screening and detection technology.